Background/Aim: Mycosis fungoides (MF) is the most common type of cutaneous T-cell lymphoma (CTCL). Differentiation of MF from its benign mimickers is important to ensure proper management. TOX is a critical regulator of early T-cell development that is considered as a useful marker for MF diagnosis and prognosis. The current study aimed to test the role of TOX immunohistochemistry (IHC) as a diagnostic marker of MF differentiating it from its benign mimickers. Materials and Methods: This work was carried out on 103 skin biopsies, 51 MF cases and 52 inflammatory mimickers. The diagnoses were established after clinicopathologic correlation. IHC was done in MF cases for TOX, CD4, CD8 and CD7 (in TOX negative cases), while the other mimickers stained only by TOX. Results: TOX expression showed a significant positive expression in MF cases compared to inflammatory dermatoses, with 62% sensitivity and 100% specificity. There was positive correlation between TOX staining and CD4/CD8 ratio in MF cases. In addition, TOX positivity in plaque MF was stronger than in patch MF. Also, TOX negative MF cases were negative for CD7. Conclusions: Positive TOX expression favors MF, but its negativity doesn't exclude the diagnosis of MF. Combining TOX with CD4/CD8 ratio and CD7 may be useful in diagnosis of MF beside the clinical and histopathological diagnosis. The stronger TOX positivity in plaque more than patch MF may correlate with the progression of the disease.
INTRODUCTION ycosis fungoides (MF) is the most common cutaneous T-cell lymphoma (CTCL)
Methodology. All archival specimens had been fixed in neutral-buffered formalin and embedded in paraffin by routine methods. Paraffin blocks of MF cases were yield to immunohistochemical staining for TOX, CD4, CD8 and CD7 (in TOX negative cases), while, the others inflammatory dermatoses stained only by TOX. For the study, the specimens were cut in 4µ thick sections on adhesive-coated glass slides. Deparaffinization with xylene and hydration through graded alcohol series were performed. Endogenous peroxidase activity was blocked by incubation with 3% hydrogen peroxidase in methanol for 5 min. Epitope retrieval was carried out by boiling in a pressure cooker with Citrate Buffer pH 6.0 for TOX and with EDTA Buffer pH 8.0 for CD4, CD8 and CD7. Sections were then incubated with proteinase K 0.04% for 5 min. After washing with phosphate-buffered saline, the sections were incubated with the antihuman monoclonal antibodies. Chicago, IL, USA). Parametric data were expressed in mean ± standard deviation. Non parametric data were expressed in median, minimum and maximum. Normality of data was first tested by one sample K-S test. In addition, independent t test was used to compare means for continuous parametric variables of each two different groups. Also, Mann-Whitney U test (z) was used to compare non parametric continuous variables in two different groups. Pearson Chi-square tests were used to compare the categorical variables between groups. Roc curve was used to estimate area under the curve (AUC), sensitivity and specificity and cutoff values indicating diagnostic accuracy of TOX expression gene in diagnosis of MF. Calculation for degree of agreement between two tests was done according to equation (Addition of product of the diagonal /total %). P value < 0.05 was considered as statistically significant.
RESULTS

Clinical characteristics of the studied cases:
The age and male gender in MF cases were significantly higher than inflammatory dermatoses group (table 1). Table 3 : ROC curve shows the diagnostic accuracy of TOX There was statistical significant increase in TOX titre in Plaque MF that showed stronger positivity more than Patch MF in our study (p=0.01) (table 4)(figure 1: photo b and c). The current study revealed positive TOX staining in only CD4+ T cells in MF cases that had valuable elevated CD4/CD8 ratio( Figure 2 ) with strong reliability (agreement) with it and its negativity (Figure 1 photo d When we stained the TOX negative cases by CD7, all of them showed negative CD7 expression. . DISCUSSION Considering the difficulty in differentiation between MF and its benign mimickers, our study was conducted to highlight the role of thymocyte selection-associated high mobility group box factor (TOX) IHC in this aspect. However, the studies in this aspect were limited, only three studies [10, 12, 13].
Regarding the age and gender of patients in our study the mean age of MF presentation was 46.09 ± 18.5 ranged between 6-78 years and male to female ratio was 2:1. The age and male gender in MF cases were significantly higher than inflammatory diseases. 
